Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Population diversification in Staphylococcus aureus biofilms may promote dissemination and persistence.

Savage VJ, Chopra I, O'Neill AJ.

PLoS One. 2013 Apr 30;8(4):e62513. doi: 10.1371/journal.pone.0062513. Print 2013.

2.

Molecular characterization of regulatory genes associated with biofilm variation in a Staphylococcus aureus strain.

Kim JH, Kim CH, Hacker J, Ziebuhr W, Lee BK, Cho SH.

J Microbiol Biotechnol. 2008 Jan;18(1):28-34.

3.

Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide.

Mitchell G, Séguin DL, Asselin AE, Déziel E, Cantin AM, Frost EH, Michaud S, Malouin F.

BMC Microbiol. 2010 Jan 30;10:33. doi: 10.1186/1471-2180-10-33.

4.

SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants.

Mitchell G, Fugère A, Pépin Gaudreau K, Brouillette E, Frost EH, Cantin AM, Malouin F.

PLoS One. 2013 May 21;8(5):e65018. doi: 10.1371/journal.pone.0065018. Print 2013.

5.

Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation.

Lauderdale KJ, Boles BR, Cheung AL, Horswill AR.

Infect Immun. 2009 Apr;77(4):1623-35. doi: 10.1128/IAI.01036-08. Epub 2009 Feb 2.

6.

A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides.

Mitchell G, Brouillette E, Séguin DL, Asselin AE, Jacob CL, Malouin F.

Microb Pathog. 2010 Jan;48(1):18-27. doi: 10.1016/j.micpath.2009.10.003. Epub 2009 Oct 13.

PMID:
19825410
7.

Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin.

Scherr TD, Hanke ML, Huang O, James DB, Horswill AR, Bayles KW, Fey PD, Torres VJ, Kielian T.

MBio. 2015 Aug 25;6(4). pii: e01021-15. doi: 10.1128/mBio.01021-15.

8.

Generation of virulence factor variants in Staphylococcus aureus biofilms.

Yarwood JM, Paquette KM, Tikh IB, Volper EM, Greenberg EP.

J Bacteriol. 2007 Nov;189(22):7961-7. Epub 2007 Aug 3.

9.

Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections.

Tuchscherr L, Bischoff M, Lattar SM, Noto Llana M, Pförtner H, Niemann S, Geraci J, Van de Vyver H, Fraunholz MJ, Cheung AL, Herrmann M, Völker U, Sordelli DO, Peters G, Löffler B.

PLoS Pathog. 2015 Apr 29;11(4):e1004870. doi: 10.1371/journal.ppat.1004870. eCollection 2015 Apr.

10.

Methicillin resistance and the biofilm phenotype in Staphylococcus aureus.

McCarthy H, Rudkin JK, Black NS, Gallagher L, O'Neill E, O'Gara JP.

Front Cell Infect Microbiol. 2015 Jan 28;5:1. doi: 10.3389/fcimb.2015.00001. eCollection 2015. Review.

11.

Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation.

Beenken KE, Mrak LN, Griffin LM, Zielinska AK, Shaw LN, Rice KC, Horswill AR, Bayles KW, Smeltzer MS.

PLoS One. 2010 May 24;5(5):e10790. doi: 10.1371/journal.pone.0010790.

12.

Phenotypic and genotypic characterisation of Staphylococcus aureus causing musculoskeletal infections.

Post V, Wahl P, Uçkay I, Ochsner P, Zimmerli W, Corvec S, Loiez C, Richards RG, Moriarty TF.

Int J Med Microbiol. 2014 Jul;304(5-6):565-76. doi: 10.1016/j.ijmm.2014.03.003. Epub 2014 Apr 3.

PMID:
24768432
13.

agr RNAIII divergently regulates glucose-induced biofilm formation in clinical isolates of Staphylococcus aureus.

Coelho LR, Souza RR, Ferreira FA, Guimarães MA, Ferreira-Carvalho BT, Figueiredo AM.

Microbiology. 2008 Nov;154(Pt 11):3480-90. doi: 10.1099/mic.0.2007/016014-0.

PMID:
18957601
14.

Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.

Hou W, Sun X, Wang Z, Zhang Y.

Invest Ophthalmol Vis Sci. 2012 Aug 17;53(9):5624-31. doi: 10.1167/iovs.11-9114.

PMID:
22736609
15.

Biofilm formation and genotyping of Staphylococcus aureus bovine mastitis isolates: evidence for lack of penicillin-resistance in Agr-type II strains.

Melchior MB, van Osch MH, Graat RM, van Duijkeren E, Mevius DJ, Nielen M, Gaastra W, Fink-Gremmels J.

Vet Microbiol. 2009 May 28;137(1-2):83-9. doi: 10.1016/j.vetmic.2008.12.004. Epub 2008 Dec 11.

PMID:
19150182
16.

A full genomic characterization of the development of a stable Small Colony Variant cell-type by a clinical Staphylococcus aureus strain.

Bui LMG, Kidd SP.

Infect Genet Evol. 2015 Dec;36:345-355. doi: 10.1016/j.meegid.2015.10.011. Epub 2015 Oct 13.

PMID:
26458527
17.

MgrA represses biofilm formation in Staphylococcus aureus.

Trotonda MP, Tamber S, Memmi G, Cheung AL.

Infect Immun. 2008 Dec;76(12):5645-54. doi: 10.1128/IAI.00735-08. Epub 2008 Oct 13.

18.

Biofilm formation and dispersal of Staphylococcus aureus under the influence of oxacillin.

Mirani ZA, Aziz M, Khan MN, Lal I, Hassan NU, Khan SI.

Microb Pathog. 2013 Aug-Sep;61-62:66-72. doi: 10.1016/j.micpath.2013.05.002. Epub 2013 May 25.

19.

Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation.

Valour F, Rasigade JP, Trouillet-Assant S, Gagnaire J, Bouaziz A, Karsenty J, Lacour C, Bes M, Lustig S, Bénet T, Chidiac C, Etienne J, Vandenesch F, Ferry T, Laurent F; Lyon BJI Study Group.

Clin Microbiol Infect. 2015 Jun;21(6):568.e1-11. doi: 10.1016/j.cmi.2015.01.026. Epub 2015 Feb 10.

20.

Biofilm formation by Scottish clinical isolates of Staphylococcus aureus.

Smith K, Perez A, Ramage G, Lappin D, Gemmell CG, Lang S.

J Med Microbiol. 2008 Aug;57(Pt 8):1018-23. doi: 10.1099/jmm.0.2008/000968-0.

PMID:
18628505

Supplemental Content

Support Center